BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6341486)

  • 41. Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.
    Indiveri MC; Hirsh DC
    J Am Vet Med Assoc; 1986 Jan; 188(1):46-8. PubMed ID: 3484737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neisseria lactamica septicemia in an immunocompromised patient.
    Schifman RB; Ryan KJ
    J Clin Microbiol; 1983 May; 17(5):934-5. PubMed ID: 6602809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Post-antibiotic effect in the treatment of infections in neutropenic patients].
    Bermudez LE
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(2):76-9. PubMed ID: 3105033
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibacterial action of trimethoprim-sulfamethoxazole.
    Gallien R
    J Infect Dis; 1973 Nov; 128():Suppl:486-97 p. PubMed ID: 4202206
    [No Abstract]   [Full Text] [Related]  

  • 45. In-vitro susceptibility of organisms isolated from burns to topical co-trimoxazole.
    Holder IA
    J Antimicrob Chemother; 1981 Jun; 7(6):623-7. PubMed ID: 6972942
    [No Abstract]   [Full Text] [Related]  

  • 46. In-vitro comparative study of Lidaprim and co-trimoxazole.
    Abdel-Messih EF; Suleiman MN; Baron JM
    J Int Med Res; 1984; 12(3):219-20. PubMed ID: 6376211
    [No Abstract]   [Full Text] [Related]  

  • 47. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergism between trimethoprim and sulfamethoxazole.
    Science; 1977 Sep; 197(4310):1300-1. PubMed ID: 331475
    [No Abstract]   [Full Text] [Related]  

  • 49. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 50. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
    Goodhart GL
    JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of sulfonamide antagonists on the synergism of sulfamethoxazole-trimethoprim in Escherichia coli.
    Then R
    Zentralbl Bakteriol Orig A; 1973 Oct; 225(1):34-41. PubMed ID: 4148900
    [No Abstract]   [Full Text] [Related]  

  • 52. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
    Riley TV; Digiovanni C; Hoyne GF
    J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiresistance plasmid from commensal Neisseria strains.
    Pintado C; Salvador C; Rotger R; Nombela C
    Antimicrob Agents Chemother; 1985 Jan; 27(1):120-4. PubMed ID: 3885843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The changing pattern of resistance to ampicillin and co-trimoxazole in Shigella serotypes in Bangalore, southern India.
    Macaden R; Bhat P
    J Infect Dis; 1985 Dec; 152(6):1348. PubMed ID: 3905991
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacterial resistance to trimethoprim-sulfamethoxazole.
    N Engl J Med; 1982 Jul; 307(1):60-2. PubMed ID: 7043275
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of co-trimoxazole on serum creatinine.
    Dijkmans BA; van Hooff JP; de Wolff FA; Mattie H
    Br J Clin Pharmacol; 1981 Nov; 12(5):701-3. PubMed ID: 6977366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Letter: Co-trimoxazole resistance.
    Then R; Angehrn P
    Br Med J; 1974 Jan; 1(5897):78-9. PubMed ID: 4590994
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antibiotic susceptibility of E. coli strains isolated from urinary tract infections and the role of metabolically deficient strains in these infections].
    Söyletir G; Günalp A
    Mikrobiyol Bul; 1985 Oct; 19(4):210-7. PubMed ID: 3913849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the effects of trimethoprim and sulfamethoxazole on human granulopoiesis.
    Bjornson BH; McIntyre AP; Harvey JM; Tauber AI
    Am J Hematol; 1986 Sep; 23(1):1-7. PubMed ID: 3488680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.